Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
about
Identifying a novel locus for psoriatic arthritisA20-Binding Inhibitor of NF-κB Activation 1 is a Physiologic Inhibitor of NF-κB: A Molecular Switch for Inflammation and AutoimmunityPharmacogenetics of treatment response in psoriatic arthritisRisk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08Association of a TNIP1 polymorphism with Vogt-Koyanagi-Harada syndrome but not with ocular Behcet's disease in Han Chinese.Intronic variants in the NFKB1 gene may influence hearing forecast in patients with unilateral sensorineural hearing loss in Meniere's diseaseTNFAIP3 gene polymorphisms in a Chinese Han population with Vogt-Koyanagi-Harada syndrome.Identification of the tyrosine-protein phosphatase non-receptor type 2 as a rheumatoid arthritis susceptibility locus in europeansEmerging roles for TNIP1 in regulating post-receptor signalingIdentifying Causal Genes at the Multiple Sclerosis Associated Region 6q23 Using Capture Hi-CSynovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical featuresAssociation of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus.JAK and STAT signaling molecules in immunoregulation and immune-mediated disease.A20: linking a complex regulator of ubiquitylation to immunity and human diseaseABIN1 dysfunction as a genetic basis for lupus nephritis.Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study.Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.The IL-23/IL-17 axis in psoriatic arthritis.Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy.Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases.Biomarkers in psoriatic arthritis: recent progress.The IL-23-IL-17 axis in inflammatory arthritis.Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis.Deletion of late cornified envelope genes, LCE3C_LCE3B-del, is not associated with psoriatic arthritis in Tunisian patients.Association between genetic variants and esophageal cancer risk.IL-21 and Sjögren's syndrome.Investigation of 20 non-HLA (human leucocyte antigen) psoriasis susceptibility loci in Chinese patients with psoriatic arthritis and psoriasis vulgaris.Investigating the genetic association of HCP5, SPATA2, TNIP1, TNFAIP3 and COG6 with psoriasis in Chinese population.Targeting IL-17 in psoriatic arthritis.Investigation of the genetic overlap between rheumatoid arthritis and psoriatic arthritis in a Greek population.TNFAIP3 gene polymorphisms confer risk for Behcet's disease in a Chinese Han population.Role of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies.Discovering Genetic Factors for psoriasis through exhaustively searching for significant second order SNP-SNP interactionsTNIP1 in Autoimmune Diseases: Regulation of Toll-like Receptor Signaling
P2860
Q26800688-603347C0-9385-48F4-B54E-4A1061901A43Q27021657-CEAE56D3-B562-4BB3-8B4A-437CFA15C317Q28081252-387735A0-CC6B-4ABF-A635-A0E693B3FB3BQ28943379-77D75FE2-2BBD-4707-8DBF-3C47B3933D44Q33559902-9D858BD4-2C43-46D1-89BD-336A820252C3Q34513628-EC1EB3AF-915C-4AD5-979D-BCC6A1E84F38Q34651381-E5276486-5A51-4795-B196-ACFC0DD1E66BQ34805476-5A99EFC1-E1EB-4278-93C0-CC9EB2733D12Q36003961-CDD2A2B0-A304-4CF3-973F-7337B913BB49Q36197435-2FB64945-9C8C-4DF1-BA8B-6E2CB76C3941Q36245883-1FA7A660-0B43-4845-A992-A54CCBE55244Q36360650-F65BFF49-E1C2-433B-B222-8DD4AB0DA37FQ36404704-1EA51AD5-456B-4754-A4D5-BC75E5323160Q36638963-F1271C31-7A1A-4EC6-83DA-4539A91CD739Q37260222-7D23138A-9045-4876-AEE3-18B8D7CE53B6Q37460616-44E02630-B9D6-4D8B-8FC4-AF2F1DFFCCE0Q37512889-38E785AB-2D21-4646-8AD5-7706FD1AAB2AQ37717133-B3E512DE-C76F-4A08-83CC-C5770AABF0DCQ37952328-569AE0E4-C455-40D8-98A4-83B6801A530BQ38071564-1D11792C-D686-482E-B45B-6703E2F7B8BDQ38075774-58C19059-DFBF-4E6E-8E99-829886B4B2A0Q38248904-722B579A-E918-49D8-A844-A0264BF2B4DAQ38439641-D1FF333B-0B09-4D2C-B78E-BE8EA94F94BEQ38458004-F712B147-E757-4B93-9031-63928CE7357AQ38799600-AC4B9DE1-2778-4B02-BE6D-442EDB9A12B7Q38944858-69CDE5F9-EB89-41F1-B44F-06F66927B27AQ41470960-6312AB2D-1821-45A3-9959-2782B2C9E4ACQ43149586-AAA4C7DB-5C80-4B8F-8725-F39438EE3B0DQ43849389-64A001A9-91D0-45E5-80AE-23D9AA59CB57Q44080470-A512E880-DA7B-498D-B2BB-BC9B0E7CD509Q47140713-25F86036-9721-4A29-BD2C-CED1645907D3Q51628046-655C7D56-D3ED-44B3-8F53-F07B5CD4E5FAQ54283225-98AF1CDE-EDF8-44A0-B144-665477FC46A8Q55265241-6D2FBF6B-113B-45E8-8DF4-E1B09774943DQ57472708-CF8C3420-E5F9-4E91-B13C-7E71E4C7AF19Q58585474-3C59B15E-7FA7-40F9-A3EA-DE30ED7B800E
P2860
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
@ast
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
@en
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
@en-gb
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
@nl
type
label
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
@ast
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
@en
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
@en-gb
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
@nl
prefLabel
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
@ast
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
@en
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
@en-gb
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
@nl
P2093
P2860
P50
P356
P1476
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
@en
P2093
Ann W Morgan
David Kane
Edward Flynn
Eleanor Korendowych
Jonathan Packham
Neil McHugh
Oliver FitzGerald
Pauline Ho
Rasha Brier
P2860
P304
P356
10.1136/ARD.2011.150102
P407
P50
P577
2011-09-01T00:00:00Z